Cargando…

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes

Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tb) still remains a devastating infectious disease in the world. There has been a daunting increase in the incidence of Type 2 Diabetes Mellitus (T2DM) worldwide. T2DM patients are three times more vulnerable to M. tb infection compared to h...

Descripción completa

Detalles Bibliográficos
Autores principales:	To, Kimberly, Cao, Ruoqiong, Yegiazaryan, Aram, Owens, James, Sasaninia, Kayvan, Vaughn, Charles, Singh, Mohkam, Truong, Edward, Sathananthan, Airani, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975622/ https://www.ncbi.nlm.nih.gov/pubmed/33966361 http://dx.doi.org/10.1515/bmc-2021-0003

Ejemplares similares

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Antimycobacterial Effects of Everolimus in a Human Granuloma Model
por: Ashley, David, et al.
Publicado: (2020)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis
por: Abnousian, Arbi, et al.
Publicado: (2023)

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections
por: Kenchappa, Vanaja, et al.
Publicado: (2022)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity
por: Cao, Ruoqiong, et al.
Publicado: (2019)

Review of the Effectiveness of Various Adjuvant Therapies in Treating Mycobacterium tuberculosis
por: Amin, Arman, et al.
Publicado: (2021)

Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
por: Hernandez, Joshua, et al.
Publicado: (2020)

Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection
por: Kelley, Melissa, et al.
Publicado: (2023)

Topical Absorption of Glutathione–Cyclodextrin Nanoparticle Complex in Healthy Human Subjects Improves Immune Response against Mycobacterium avium Infection
por: Sasaninia, Kayvan, et al.
Publicado: (2023)

Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes
por: Lagman, Minette, et al.
Publicado: (2015)

Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
por: Abrahem, Rachel, et al.
Publicado: (2019)

Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis
por: Ferlita, Steve, et al.
Publicado: (2019)

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023)

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)

Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)

Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival
por: Pascoe, Jordan, et al.
Publicado: (2020)

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
por: Cerni, Stephen, et al.
Publicado: (2019)

Liposomal Glutathione Supplementation Restores T(H)1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals
por: Ly, Judy, et al.
Publicado: (2015)

Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection
por: Raien, Anmol, et al.
Publicado: (2023)

Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
por: Ludannyy, R., et al.
Publicado: (2015)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
por: Espinosa-Cueto, Patricia, et al.
Publicado: (2020)

BCG vaccine: Disseminated Mycobacterium bovis infection: case report
Publicado: (2021)

Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022)

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
por: Berrêdo-Pinho, Marcia, et al.
Publicado: (2011)

Complete Genome Sequence of Mycobacterium bovis BCG SL222 Sofia, the First WHO Reference Reagent for the M. bovis BCG Vaccine of the Russian BCG-I Substrain
por: Panaiotov, Stefan, et al.
Publicado: (2021)

Rifampin-Resistant Mycobacterium bovis BCG–Induced Disease in HIV-Infected Infant, Vietnam
por: Hong, Duc Nguyen, et al.
Publicado: (2013)

Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress
por: Gallant, James L., et al.
Publicado: (2016)

Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG
por: Carroll, Maria V., et al.
Publicado: (2010)

Complete Genome Sequence of Mycobacterium bovis Strain BCG-1 (Russia)
por: Sotnikova, Evgeniya A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qjbqsalil1rncladpsalcll109